Patents by Inventor Young-Wook CHIN

Young-Wook CHIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition and healthy food composition with sp. KCCM 11826P for preventing or treating hyperphosphatemia in chronic kidney disease
    Patent number: 11123385
    Abstract: Provided are a functional food or pharmaceutical composition or a method for preventing, alleviating or treating hyperphosphatemia and chronic kidney disease and treating chronic kidney disease using the composition comprising Lactobacillus sp. KCCM 11826P having excellent phosphorus-absorbing ability.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: September 21, 2021
    Assignees: Korea Food Research Institute, Catholic Kwandong University Industry Foundation
    Inventors: Hyo Jin Kim, Hae Won Jang, Young-Wook Chin, Woo Kyung Kang, Sung Jin Moon
  • Method of producing 2?-fucosyllactose using recombinant
    Patent number: 10876122
    Abstract: Provided is a method of producing 2?-fucosyllactose including culturing in a medium supplemented with lactose a recombinant Corynebacterium glutamicum transformed to express ?-1,2-fucosyltransferase, transformed to express GDP-D-mannose-4,6-dehydratase, transformed to express GDP-L-fucose synthase, and transformed to express lactose permease, wherein the recombinant Corynebacterium glutamicum has phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: December 29, 2020
    Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, ADVANCED PROTEIN TECHNOLOGIES CORP.
    Inventors: Jin-Ho Seo, Young-Wook Chin, Hae-Yong Jo
  • Corynebacterium glutamicum for use in producing 2?-fucosyllactose
    Patent number: 10570399
    Abstract: Disclosed are a recombinant Corynebacterium glutamicum (C. glutamicum) for producing fucosyllactose which is transformed to express ?-1,2-fucosyltransferase, GDP-D-mannose-4,6-dehydratase (Gmd), GDP-L-fucose synthase (WcaG) and lactose permease (LacY), wherein the Corynebacterium glutamicum has phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase, and a method for producing fucosyllactose using the same. According to the recombinant Corynebacterium glutamicum and the method for producing fucosyllactose according to the present invention, with use of a GRAS Corynebacterium glutamicum strain, which is safer than conventional Escherichia coli, 2?-fucosyllactose can be produced at a high concentration while overcoming drawbacks of conventional methods associated with industrial inapplicability resulting from low production concentrations.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: February 25, 2020
    Assignee: Seoul National University R&DB Foundation
    Inventors: Jin-Ho Seo, Young-Wook Chin, Hae-Yong Jo
  • CORYNEBACTERIUM GLUTAMICUM FOR USE IN PRODUCING 2'-FUCOSYLLACTOSE
    Publication number: 20200048640
    Abstract: Provided is a method of producing 2?-fucosyllactose including culturing in a medium supplemented with lactose a recombinant Corynebacterium glutamicum transformed to express ?-1,2-fucosyltransferase, transformed to express GDP-D-mannose-4,6-dehydratase, transformed to express GDP-L-fucose synthase, and transformed to express lactose permease, wherein the recombinant Corynebacterium glutamicum has phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase.
    Type: Application
    Filed: October 1, 2019
    Publication date: February 13, 2020
    Applicants: Seoul National University R&DB Foundation, AP Technologies Corp.
    Inventors: Jin-Ho SEO, Young-Wook CHIN, Hae-Yong JO
  • PHARMACEUTICAL COMPOSITION AND HEALTHY FOOD COMPOSITION WITH LACTOBACILLUS SP. KCCM 11826P FOR PREVENTING OR TREATING HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE
    Publication number: 20190240270
    Abstract: Provided are a functional food or pharmaceutical composition or a method for preventing, alleviating or treating hyperphosphatemia and chronic kidney disease and treating chronic kidney disease using the composition comprising Lactobacillus sp. KCCM 11826P having excellent phosphorus-absorbing ability.
    Type: Application
    Filed: January 26, 2017
    Publication date: August 8, 2019
    Applicants: KOREA FOOD RESEARCH INSTITUTE, Catholic Kwandong University Industry Foundation
    Inventors: Hyo Jin KIM, Hae Won JANG, Young-Wook CHIN, Woo Kyung KANG, Sung Jin MOON
  • METHOD OF PRODUCING 2'-FUCOSYLLACTOSE USING CORYNEBACTERIUM GLUTAMICUM
    Publication number: 20180298389
    Abstract: Disclosed are a recombinant Corynebacterium glutamicum (C. glutamicum) for producing fucosyllactose which is transformed to express ?-1,2-fucosyltransferase, GDP-D-mannose-4,6-dehydratase (Gmd), GDP-L-fucose synthase (WcaG) and lactose permease (LacY), wherein the Corynebacterium glutamicum has phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase, and a method for producing fucosyllactose using the same. According to the recombinant Corynebacterium glutamicum and the method for producing fucosyllactose according to the present invention, with use of a GRAS Corynebacterium glutamicum strain, which is safer than conventional Escherichia coli, 2?-fucosyllactose can be produced at a high concentration while overcoming drawbacks of conventional methods associated with industrial inapplicability resulting from low production concentrations.
    Type: Application
    Filed: April 24, 2017
    Publication date: October 18, 2018
    Applicants: Seoul National University R&DB Foundation, AP Technologies Corp.
    Inventors: Jin-Ho SEO, Young-Wook CHIN, Hae-Yong JO